Ekaterina Kotelnikova
Associate Director for Discovery and Translational Science Consulting
Ekaterina is a highly experienced professional in bioinformatics consulting, with over 20 years of expertise in bioinformatics and systems biology. She holds a Ph.D. in molecular evolution and has a background in biophysics. Throughout her career, Ekaterina has led teams in both academic and commercial settings, specializing in drug discovery, patient subpopulation selection, and precision medicine applications using multi-omics approaches, network, and pathway analysis. She has been actively involved in establishing partnerships with interdisciplinary teams and has made significant contributions to grant applications and deliveries.
Driven by her passion for translational medicine, Ekaterina co-founded a company dedicated to NGS-based cancer treatment predictions. Working closely with molecular oncologists, bioinformaticians, and systems biologists, the company focused on the application of systems biology to precision medicine, benefiting from seed investments and grants.
Ekaterina plays a crucial role in client-facing activities and business development, conducting client needs assessments, exploring market opportunities, proposing innovative solutions, and successfully overseeing project management across various therapy areas, including oncology, neuromuscular, skin, rare, and autoimmune diseases.
Latest news
Clarivate’s IPfolio and Renewal Services Selected by IGT
Managing global intellectual property more efficiently with trusted data, expert support and integrated services London, U.K. May 21, 2026: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today…
Clarivate Selected By Czech National Library of Technology to Develop Unified National Library Platform
New cloud-based, shared platform based on Alma and Primo to help National Library of Technology advance library services and information accessibility London, U.K. May 19, 2026: Clarivate Plc (NYSE:CLVT), a…
